News

The two New York Stock Exchange-listed funds are due to start trading on Wednesday.

Consumers in other countries are boycotting US products and limiting tourism — a trend that could register a hit to GDP.

Trump Media, which operates the Truth Social platform and is primarily owned by Trump, filed to re-register shares that would allow Trump's trust to potentially sell $2.3 billion worth of the company's stock. Existing shareholders in the company -- which include U.S. Attorney General Pam Bondi and Trump Media & Technology Group Chairman Devin Nunes -- are also looking to sell a total of 134 million shares, according to the filing.

With an international intermodal surge winding down, analyst Larry Gross pins his hopes on domestic intermodal share gains. The post Analyst: Intermodal facing volume headwinds from tariffs, economic uncertainty appeared first on FreightWaves.

Eased policy in China — and signs of this are emerging — could significantly boost bitcoin adoption

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

The Russell 2000 is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.5%. This drop was worse than the S&P 500’s 2.3% loss.